FDA Approved: PAROXETINE — Supplemental Application (Mylan Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved a supplemental application from Mylan Pharmaceuticals for paroxetine hydrochloride hemihydrate, authorizing a generic version of paroxetine.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Generalized Anxiety Disorder
• Major Depressive Disorder
• Obsessive-compulsive Disorder
• Panic Disorder
• Post-traumatic Stress Disorder
• Premenstrual Dysphoric Disorder
• Social Anxiety Disorder

Drugs mentioned

• Paroxetine hydrochloride hemihydrate (Paroxetine)

Snippet

SUPPL AP for PAROXETINE (PAROXETINE HYDROCHLORIDE HEMIHYDRATE)